We are live on
!
Find out more
PCA
Private Capital Advisors Portfolio holdings
AUM
$1.15B
Turnover
18.82%
1-Year Est. Return
43.46%
This Fund
S&P 500
This Quarter
Est. Return
-0.76%
1 Year Est. Return
+43.46%
3 Year Est. Return
+131.91%
5 Year Est. Return
+229.29%
10 Year Est. Return
+757.55%
AUM
$307M
AUM Growth
+$31.9M
(+12%)
Cap. Flow
+$40.1M
Cap. Flow
% of AUM
13.06%
Top 10 Holdings %
Top 10 Hldgs %
24.74%
Holding
140
New
26
Increased
30
Reduced
34
Closed
7
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
+$9.59M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$6.03M |
| 3 |
GE Aerospace
GE
|
+$5.63M |
| 4 |
Meta Platforms (Facebook)
META
|
+$4.15M |
| 5 |
Comcast
CMCSA
|
+$2.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$4.53M |
| 2 |
MacroGenics
MGNX
|
+$1.86M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$1.43M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$1.26M |
| 5 |
EOG Resources
EOG
|
+$1.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.28% |
| 2 | Communication Services | 20.72% |
| 3 | Energy | 14.2% |
| 4 | Industrials | 11.62% |
| 5 | Technology | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Charter Communications
CHTR
$12.6B
| $890K | 0.29% |
5,200
| – | – |
2013 Q2
8 quarters
|
|
77
CVS Health
CVS
$118B
| $886K | 0.29% |
8,450
| – | – |
2013 Q2
8 quarters
|
|
78
Opko Health
OPK
$1.14B
| $836K | 0.27% |
+52,000
| New | +$809K |
2015 Q2
0 quarters
|
|
79
Wynn Resorts
WYNN
$7.78B
| $789K | 0.26% |
+8,000
| New | +$903K |
2015 Q2
0 quarters
|
|
|
IMMP
80
Immutep
IMMP
$23.6M
| $754K | 0.25% |
+7,800
| New | +$708K |
2015 Q2
0 quarters
|
|
81
Invesco QQQ Trust
QQQ
$475B
| $716K | 0.23% |
6,690
| – | – |
2013 Q2
8 quarters
|
|
82
Ball Corp
BALL
$16.7B
| $706K | 0.23% |
20,120
| – | – |
2013 Q2
8 quarters
|
|
83
Coca-Cola
KO
$404B
| $706K | 0.23% |
18,000
| – | – |
2013 Q2
8 quarters
|
|
84
Zillow
ZG
$7.17B
| $694K | 0.23% |
24,000
| – | – |
2015 Q1
1 quarter
|
|
85
Microsoft
MSFT
$3.93T
| $657K | 0.21% |
14,875
| – | – |
2013 Q2
8 quarters
|
|
86
BioMarin Pharmaceuticals
BMRN
$10.6B
| $643K | 0.21% |
+4,700
| New | +$582K |
2015 Q2
0 quarters
|
|
87
Intuit
INTU
$86.9B
| $620K | 0.2% |
6,150
| – | – |
2013 Q2
8 quarters
|
|
88
Las Vegas Sands
LVS
$24.6B
| $605K | 0.2% |
+11,500
| New | +$614K |
2015 Q2
0 quarters
|
|
89
Oracle
ORCL
$389B
| $587K | 0.19% |
14,555
| – | – |
2013 Q2
8 quarters
|
|
|
ICPT
90
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $579K | 0.19% |
2,400
-4,750
| -66% | -$1.26M |
2015 Q1
1 quarter
|
|
91
American Electric Power
AEP
$69.2B
| $572K | 0.19% |
10,790
| – | – |
2013 Q2
8 quarters
|
|
|
BOJA
92
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $566K | 0.18% |
+23,714
| New | +$598K |
2015 Q2
0 quarters
|
|
93
Agios Pharmaceuticals
AGIO
$1.87B
| $533K | 0.17% |
+4,800
| New | +$517K |
2015 Q2
0 quarters
|
|
94
Occidental Petroleum
OXY
$62.4B
| $517K | 0.17% |
6,661
| – | – |
2013 Q2
8 quarters
|
|
95
Fiserv Inc
FISV
$25.3B
| $505K | 0.16% |
12,200
| – | – |
2013 Q2
8 quarters
|
|
96
Merck
MRK
$360B
| $484K | 0.16% |
8,908
| – | – |
2013 Q2
8 quarters
|
|
97
Shake Shack
SHAK
$2.83B
| $479K | 0.16% |
+7,950
| New | +$543K |
2015 Q2
0 quarters
|
|
98
Bristol-Myers Squibb
BMY
$122B
| $472K | 0.15% |
7,097
| – | – |
2013 Q2
8 quarters
|
|
99
Cencora
COR
$65.1B
| $472K | 0.15% |
4,436
| – | – |
2013 Q2
8 quarters
|
|
100
T. Rowe Price
TROW
$21.5B
| $461K | 0.15% |
5,930
| – | – |
2013 Q2
8 quarters
|
|
Similar funds
WB
AIC
CFP
HT
AA
CIG
CIS
FWM
Private Capital Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, Private Capital Advisors held 140 positions worth $307M, up 12% from $275M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Private Capital Advisors deployed $40.1M of net new capital in Q2 2015, opening 26 new positions and adding to 30 existing holdings. Its largest new stake was Thermo Fisher Scientific: 46,230 shares worth $6M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $4.53M trimmed.
- Private Capital Advisors's largest Q2 2015 buy was Thermo Fisher Scientific: 46,230 shares worth $6M.
- Private Capital Advisors added most to Trillium Therapeutics Inc. in Q2 2015, an estimated $9.59M increase.
- Private Capital Advisors's biggest Q2 2015 reduction was Ionis Pharmaceuticals, cutting an estimated $4.53M.
- Private Capital Advisors fully exited Twitter, Inc. in Q2 2015, selling an estimated $1.43M.
- Private Capital Advisors's ten largest holdings make up 25% of its $307M portfolio in Q2 2015.
- Private Capital Advisors opened 26 new positions and closed 7 in Q2 2015.
- Private Capital Advisors's portfolio value rose 12% quarter-over-quarter to $307M.
Based on Private Capital Advisors's 13F filing for Q2 2015, filed 6 Aug 2015.